603193.SS SHH
Runben Biotechnology
1W: -1.9%
1M: -2.1%
3M: +5.2%
YTD: -15.3%
1Y: -35.4%
¥20.25 ($3.02)
+0.25 (+1.25%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$2.2B
+9.9% ▲
5Y CAGR: +68.3%
Total Liabilities
$139M
+42.3% ▲
5Y CAGR: +38.7%
Shareholders Equity
$2.1B
+8.3% ▲
5Y CAGR: +72.2%
Cash & Investments
$1.4B
+415.8% ▲
5Y CAGR: +107.3%
Total Debt
$1M
-30.6% ▼
Net Debt
-$105M
+56.1% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $40M | $206M | $368M | $244M | $107M |
| Short-Term Investments | $42M | $56M | $8M | $19M | $1.2B |
| Cash & ST Investments | $82M | $262M | $376M | $263M | $1.4B |
| Net Receivables | $4M | $0 | $7M | $9M | $18M |
| Inventory | $45M | $57M | $103M | $93M | $119M |
| Other Current Assets | $7M | $0 | $16M | $1.3B | $91M |
| Total Current Assets | $142M | $344M | $510M | $1.7B | $1.6B |
| Property, Plant & Equip. | $109M | $208M | $278M | $260M | $268M |
| Goodwill & Intangibles | $21M | $20M | $19M | $19M | $55M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $3M | $69M | $4M | $3M | $258M |
| Total Non-Current Assets | $135M | $302M | $315M | $303M | $625M |
| Total Assets | $276M | $646M | $825M | $2.0B | $2.2B |
| — Liabilities — | |||||
| Accounts Payable | $13M | $46M | $48M | $53M | $61M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $1M |
| Deferred Revenue | $3M | $26M | $46M | $6M | $0 |
| Other Current Liabilities | $10M | $4M | $3M | $21M | $15M |
| Total Current Liabilities | $24M | $76M | $97M | $95M | $137M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $2M | $9M | $6M | $2M | $2M |
| Total Liabilities | $26M | $85M | $103M | $98M | $139M |
| — Equity — | |||||
| Common Stock | $103M | $344M | $344M | $405M | $405M |
| Retained Earnings | $21M | $95M | $240M | $453M | $595M |
| Accumulated OCI | $126M | $123M | $138M | $0 | $0 |
| Total Stockholders Equity | $250M | $562M | $723M | $1.9B | $2.1B |
| Total Liabilities & Equity | $276M | $646M | $825M | $2.0B | $2.2B |
| — Key Metrics — | |||||
| Total Debt | $0 | $10M | $8M | $2M | $1M |
| Net Debt | -$40M | -$196M | -$360M | -$240M | -$105M |
| Total Investments | $42M | $56M | $8M | $19M | $1.2B |